Estrogen signaling crosstalk: Implications for endocrine resistance in ovarian cancer

Jennifer R Ribeiro1, Richard N Freiman2

  • 1Brown University, Pathobiology Graduate Program, 70 Ship St., Providence, RI 02903, USA.

Insights

Ovarian cancer resistance to anti-estrogen therapies is a major challenge. Understanding estrogen signaling crosstalk with oncogenic pathways is key to improving treatments for endocrine-resistant ovarian tumors.

Area of Science:

  • Oncology
  • Endocrinology
  • Molecular Biology

Background:

  • Anti-estrogen therapies are crucial for ovarian cancer treatment.
  • Endocrine resistance in ovarian tumors limits treatment efficacy.
  • Tumors adapt by utilizing alternative oncogenic signaling pathways that interact with estrogen signaling.

Purpose of the Study:

  • To provide an overview of estrogen signaling in ovarian cancer.
  • To discuss challenges in anti-estrogen therapies.
  • To review crosstalk between estrogen signaling and oncogenic cascades.

Main Methods:

  • Literature review of estrogen signaling pathways.
  • Analysis of genomic and non-genomic estrogen signaling.
  • Examination of crosstalk with major oncogenic signaling cascades.

Main Results:

  • Estrogen signaling plays a complex role in ovarian cancer.
  • Crosstalk with oncogenic pathways contributes to endocrine resistance.
  • Genomic and non-genomic pathways exhibit significant interactions.

Conclusions:

  • Understanding estrogen signaling crosstalk is essential for overcoming resistance.
  • Current strategies target endocrine-resistant ovarian tumors.
  • New therapeutic strategies may emerge from insights into signaling crosstalk.

Related Concept Videos

Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
58.4K
Endocrine Signaling01:45

Endocrine Signaling

Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
53.7K
Endocrine Signaling01:45

Endocrine Signaling

5.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K
Autocrine Signaling01:01

Autocrine Signaling

Autocrine signaling is one of the many signaling mechanisms that function inside multicellular organisms to carry out intercellular communication. In this type of signaling mechanism, the same cell that secretes an extracellular signaling molecule also expresses the receptors to bind and respond to that signaling molecule.
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
42.2K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K